PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 134.00
+2.00 (1.52%)
Oct 26, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Revenue
PRISM BioLab Co.,LTD had revenue of 116.68M JPY in the quarter ending June 30, 2026, with 29.18% growth. This brings the company's total for the last twelve months to 737.27M, up 84.85% year-over-year. In the fiscal year ending September 30, 2025, PRISM BioLab Co.,LTD had annual revenue of 677.33M with 121.62% growth. That makes PRISM BioLab Co.,LTD the 40,182nd largest company in the world by revenue and 3,813th in Japan.
Revenue (ttm)
737.27M
Revenue Growth
+84.85%
P/S Ratio
6.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.95B
Revenue by Geography
- United States of America 523.50M 77.3%
- Japan 110.00M 16.2%
- Switzerland 43.83M 6.5%
Fiscal year ended Sep 30, 2025 See the full PRISM BioLab Co.,LTD breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 677.33M | 371.71M | 121.62% |
| Sep 30, 2024 | 305.62M | 192.69M | 170.64% |
| Sep 30, 2023 | 112.93M | -441.07M | -79.62% |
| Sep 30, 2022 | 554.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.